Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00051363 · ClinicalTrials.gov registry record · Phase 3
Apnea Positive Pressure Long-Term Efficacy Study
A Phase 3 study of Sleep and Lung Diseases, sponsored by Stanford University.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,105
- Enrollment target
- 5
- Study locations
NCT00051363 is a Phase 3 study of Sleep and Lung Diseases that has completed, run by Stanford University. The registered enrollment target is 1,105 participants, below the 4,159-participant average among 151 other Sleep trials with a reported enrollment target (73% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT00051363, a Phase 3 study of Sleep and Lung Diseases, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,105 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to determine the effectiveness of nasal continuous positive airway pressure (CPAP) therapy for the treatment of obstructive sleep apnea syndrome (OSAS).
Conditions Studied
Interventions
- DEVICE Active CPAP
- DEVICE Sham CPAP
Study Locations (5)
Arizona
- University of Arizona AHSC - Tucson
California
- Stanford University School of Medicine - Palo Alto
Massachusetts
- Brigham & Women's Hospital - Boston
Missouri
- St. Luke's Hospital - Chesterfield
Washington
- St. Mary Medical Center - Walla Walla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,105 participants |
| Start Date | 2002-09 |
| Est. Completion | 2008-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00051363
The ClinicalTrials.gov registry entry for NCT00051363 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,159-participant average among 151 other Sleep trials with a reported enrollment target (73% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which Active CPAP is the first listed.
NCT00051363 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00051363 about?
NCT00051363 is a clinical study titled "Apnea Positive Pressure Long-Term Efficacy Study". The purpose of this study is to determine the effectiveness of nasal continuous positive airway pressure (CPAP) therapy for the treatment of obstructive sleep apnea syndrome (OSAS).
What is the current status of trial NCT00051363?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,105 participants. The study started on 2002-09. Estimated completion is 2008-09.
What conditions does trial NCT00051363 study?
This clinical trial studies the following conditions: Sleep, Lung Diseases, Sleep Apnea Syndromes.
What interventions are being tested in trial NCT00051363?
The interventions under investigation include: Active CPAP (DEVICE), Sham CPAP (DEVICE).
Who is sponsoring clinical trial NCT00051363?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00051363 being conducted?
This trial has 5 study locations across Arizona, California, Massachusetts, Missouri, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lemborexant Treatment of Insomnia Linked to Epilepsy
RECRUITING · Phase 3
-
Repurposing Low-Dose Clonidine for PTSD in Veterans
RECRUITING · Phase 3
-
Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEEP)
RECRUITING · Phase 1
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Research Framework Exploring Sleep Health
RECRUITING
-
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.